United Therapeutics (UTHR) insider reports six recent sales totaling $22.05M

Rhea-AI Filing Summary

UNITED THERAPEUTICS (UTHR) Form 144 summary: This notice reports proposed sale of 11,000 common shares to be executed through Morgan Stanley Smith Barney on 10/02/2025 on NASDAQ, with an aggregate market value listed as $4,802,572.50. The shares were acquired the same day by stock option exercise and paid in cash. The filer discloses six prior common-stock sales by the same person in the past three months, each for 11,000 shares, totaling 66,000 shares and gross proceeds of approximately $22,050,034.60. The issuer’s outstanding shares are reported as 45,226,262, making each 11,000-share block a small fraction of outstanding stock. The filer certifies no undisclosed material adverse information and signs the notice under penalties for false statements.

Positive

• Compliance disclosure: The filer provided required Rule 144 details including broker, acquisition date, payment method, and prior sales
• Payment in cash for the acquired shares (stock option exercise settled in cash) reduces complexity of the transaction

Negative

• Recurring insider sales: Six prior 11,000-share sales in the past three months plus a proposed additional 11,000-share sale (total 66,000 shares sold recently)
• Material proceeds: Prior three-month gross proceeds approximately $22,050,034.60, indicating significant insider monetization activity

Insights

Corporate Governance Analyst

Insider is selling recurring blocks of shares via Rule 144; filings show regular monetization.

The filing shows the same person sold six 11,000-share blocks in the past three months and is proposing another 11,000-share sale on 10/02/2025, all through Morgan Stanley. Such recurring Rule 144 sales indicate the insider is converting equity to cash on a repeated basis rather than a single one‑off transaction. This is notable for shareholders because repeated insider sales can reflect personal liquidity actions rather than changes to company fundamentals.

Securities Compliance Specialist

Filing documents acquisition and payment method and affirms compliance statements.

The notice explicitly states the 11,000 shares to be sold were acquired on 10/02/2025 by stock option exercise and paid in cash, and the filer makes the required representation about absence of undisclosed material adverse information. The form identifies the broker and exchange and includes prior 144 sales with gross proceeds, meeting the disclosure elements required under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11000	4802572.50	45226262	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/02/2025	Stock Option Exercise	Issuer			11000	10/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	09/18/2025	11000	4467907.40
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	09/04/2025	11000	4237280.30
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	08/21/2025	11000	3396248.90
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	08/07/2025	11000	3299980.20
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	07/24/2025	11000	3345224.30
PAUL MAHON 1000 SPRING STREET SILVER SPRING MD 20910	Common	07/10/2025	11000	3303393.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for UTHR disclose?

The filing discloses a proposed sale of 11,000 common shares on 10/02/2025 through Morgan Stanley on NASDAQ, acquired by stock option exercise and paid in cash.

Who is the selling party named in the filing for UTHR?

The filings show sales by Paul Mahon (address listed) as the person for whose account the securities were sold.

How many shares and proceeds were sold by the insider in the past three months?

Six sales of 11,000 shares each (total 66,000 shares) with combined gross proceeds of about $22,050,034.60.

How large is the proposed sale relative to outstanding shares?

The issuer reports 45,226,262 outstanding shares; an 11,000-share block is a small fraction (about 0.024%) of outstanding stock.

How were the newly acquired shares paid for according to the filing?

The filing states the shares acquired on 10/02/2025 were from a stock option exercise and payment was made in cash.